Emcure Pharmaceuticals Limited — JV/Acquisition, 01-04-2026: Acquisition

Emcure Pharma's step-down subsidiary, Mantra Pharma Inc., has acquired 100% of Canada-based Cutimed Inc. for up to CAD $5.05 million (approx. ₹30.3 Cr). Cutimed, specializing in dermatological and cosmetic products, will integrate into Mantra. This strategic move is set to significantly boost Emcure's product portfolio in the Canadian market, especially in dermatology and cosmetics. It aims to consolidate Canadian operations, drive long-term growth, and achieve operational efficiencies. This acquisition aligns perfectly with Emcure's core business, strengthening its market presence and expanding its specialized offerings.